01 · The Goal

Regenerate the damaged airways the body cannot replace on its own

The goal is to regenerate damaged airways — rebuilding damaged airways that carry air deep into the lungs. For the people living this every day, it is not an abstraction — it is the difference between loss and a life regained.

02 · Why It Matters

The lungs exchange the oxygen every cell needs, and damaged airways and scarred lung tissue — from COPD, fibrosis, and injury — leave millions short of breath, with little that reverses the loss. Protecting the lungs, regenerating airway and alveolar tissue, and restoring breathing capacity would transform chronic lung disease. Every breath depends on it — and for millions short of breath, restoring the lungs is restoring the freedom to live.

03 · What We’re Trying to Achieve

We are building the capability to regrow damaged airways: from stem cells, engineered tissue, and the biology that drives true regeneration. The aim is a clear path from what already works in the clinic today to the regenerative science advancing toward tomorrow — honestly staged at every step.

04 · How It Works

How it works

Stem-cell and tissue therapies Demonstrated in research

Lab-grown cells and tissue regrow structure in animal studies and early trials.

Engineered tissue Frontier

Building functional replacement tissue in the lab is an advancing frontier.

Regeneration in the body Frontier

Coaxing the body to regenerate the tissue itself is early-stage laboratory science.

Engineered tissue & integration Clinical

Building functional, blood-supplied replacement tissue — and getting it to integrate and last — is advancing from the lab toward the clinic.

05 · Who’s Building It

Cited as evidence the capability is real — not as partners or endorsers.

Government & programs

National Heart, Lung, and Blood Institute (NHLBI, NIH) · NIH lung-regeneration programs. These public programs fund the foundational research that shows the capability is real.

Universities & institutes

Academic pulmonary, lung-regeneration, and airway-biology research centers. Academic laboratories carry that science from discovery toward the clinic.

Enabling science base

lung stem cells · alveolar & airway biology · anti-fibrotic therapy · lung tissue engineering. — the established disciplines this capability is built upon.

06 · Technologies

The technologies: lung stem-cell and regeneration biology, anti-fibrotic therapies that slow scarring, airway-repair approaches, and protective measures against inhaled damage.

07 · Breakthroughs

Cell therapy Demonstrated

Cells regrow structure in research.

Engineered tissue Frontier

Replacement tissue is advancing in the lab.

In-body regeneration Frontier

Regenerating in place is early-stage.

From bench toward bedside Clinical trials

The first regenerative therapies have entered human trials — the transition from demonstrated regrowth toward real treatment.

08 · Remaining Challenges

The honest challenges: regrowing cells is increasingly possible; building functional, integrated, durable tissue in people is the largely frontier challenge. Regrowing cells is increasingly within reach; building functional, blood-supplied, lasting tissue inside a living person is the harder, largely frontier challenge — and the one the field is racing to solve. Every line here is tagged for its real stage, so what is demonstrated is never confused with what is deployed.

09 · Mature Capability

The future, fully built

Damaged airways that the body cannot replace is regenerated — regrown, engineered, and restored — so loss becomes repairable. — staged plainly here, so the promise is always measured against the proof.

Honest boundary: each item is tagged for where it stands — demonstrated, clinical, or frontier. The science is real, funded, and accelerating. AI supports human clinicians; it never replaces them.
10 · Evidence Vault

The proof, for this capability

Cited as evidence the capability is real, not as partners or endorsers.

Cell therapy

Cells regrow structure in research and early trials. Stage: Demonstrated.

Engineered tissue

Replacement tissue is advancing. Stage: Frontier.

In-body regeneration

Regenerating in place is early-stage. Stage: Frontier.

Honest framing

Real organizations are cited as evidence the capability is real — not as partners or endorsers. Full functional regeneration in people is frontier and not claimed as routine.

Where it stands

Each line above is tagged for its stage — demonstrated, clinical, or frontier — so the page shows exactly how far the real science has come, and how far is left.

Help build this future

Every signature grows the movement to make airway regeneration real — and free at the point of need.

Paid for by Michael Floyd for President.

Scroll to Top